查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球局部给药市场~2027年：按产品、给药途径、最终用户、分销渠道、地区、市场预测、增长机会的竞争分析
市场调查报告书
商品编码
1101535

全球局部给药市场~2027年：按产品、给药途径、最终用户、分销渠道、地区、市场预测、增长机会的竞争分析

Global Topical Drug Delivery Market, By Product By Route of Administration By End-User By Distribution Channel By Region, Competition Forecast & Opportunities, 2027
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球局部给药市场预计在预测期内将以稳定的复合年增长率增长。

全球烧伤病例增加和透皮给药系统进步等因素正在推动市场需求。此外，非侵入性治疗因其成本效益和患者快速康復而受到青睐，预计将进一步影响未来五年的市场增长。

按产品划分，半固体製剂行业领先市场，预计在预测期内将保持其地位。增加的手术和器官移植正在推动该行业的需求。

本报告调查了全球局部给药市场，包括市场概况、市场规模趋势/预测、按类别/地区/主要国家分类的细分、市场上各种影响因素的分析、竞争环境、市场份额、主要公司简介等

第一章产品概述

第二章调查方法

第 3 章执行摘要

第 4 章 COVID-19 对全球局部给药市场的影响

第五章客户反馈

第 6 章全球本地药物输送市场展望

  • 市场规模/预测
  • 市场份额/预测
    • 副产品（半固体产品、液体产品、固体产品、透皮产品）
    • 通过给药途径（经皮、眼科、直肠、阴道、鼻腔）
    • 按最终用户（医院、诊所、家庭保健、诊断中心等）
    • 按分销渠道（线上/线下）
    • 按公司
    • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
  • 产品市场图

第 7 章北美局部给药市场展望

  • 市场规模/预测
  • 市场份额/预测
    • 按产品
    • 按给药途径
    • 最终用户
    • 按分销渠道
    • 按国家/地区

第 8 章欧洲局部给药市场展望

  • 市场规模/预测
  • 市场份额/预测
    • 按产品
    • 按给药途径
    • 最终用户
    • 按分销渠道
    • 按国家/地区

第 9 章亚太地区局部给药市场展望

  • 市场规模/预测
  • 市场份额/预测
    • 按产品
    • 按给药途径
    • 最终用户
    • 按分销渠道
    • 按国家/地区

第 10 章中东和非洲局部给药市场展望

  • 市场规模/预测
  • 市场份额/预测
    • 按产品
    • 按给药途径
    • 最终用户
    • 按分销渠道
    • 按国家/地区

第 11 章南美本地药物输送市场展望

  • 市场规模/预测
  • 市场份额/预测
    • 按产品
    • 按给药途径
    • 最终用户
    • 按分销渠道
    • 按国家/地区

第12章市场动态

  • 促进因素
  • 挑战

第 13 章市场趋势/市场发展

第14章竞争态势

  • 竞争前景
  • 全球公司简介（主要公司）
    • Johnson & Johnson SA
    • Nestle SA
    • GlaxoSmithKline Plc
    • Novartis AG
    • Merck & Co. Inc.
    • Crescita Therapeutics Inc.
    • Cipla Ltd.
    • Taro Pharmaceutical Industries Ltd.
    • Valeant Pharmaceuticals International Inc.
    • Glenmark Pharmaceuticals Ltd.
    • Bayer AG
    • Encore Dermatology, Inc.
    • MedPharm Group Ltd.
    • Skinvisible Pharmaceuticals, Inc.
    • Galderma S.A.

第15章 策略建议

简介目录
Product Code: 7362

The global topical drug delivery market is anticipated to witness a growth with a steady CAGR in the forecast period, 2023-2027. Factors such as increased incidence of burn injuries across the globe and advancements in the transdermal drug delivery systems are primarily driving the market demand. The rise at the old age population who prefer to use tropical drug delivery as it eases the drug delivery process fuels the market demand. Also, the growing popularity of the non-invasive procedures due to their cost-effectiveness and fast healing among patients is further expected to influence the market growth in the next five years.

The global topical drug delivery market is segmented into product, route of administration, end user, distribution channel, regional distribution, and competitive landscape. Based on product, the market is fragmented into semi-solid formulations, liquid formulations, solid formulations, and transdermal products. Semi-solid formulations dominate the market and are anticipated to maintain their dominance over the forecast period, 2023-2027. Lotions, creams, gels, pastes, ointments, and other semi-solid formulations are some examples of semi-solid formulations that are used topically. These formulations are absorbed through the skin, and the therapeutic ingredients do the same, penetrating the skin to enter the body's bloodstream through tiny capillaries. They fix any damage or abnormality in the epidermal tissues that cover the surface of the body. The rise in the number of surgeries and organ transplantation procedures is driving the segment demand.

The major market players operating in the global topical drug delivery market are Johnson & Johnson SA, Nestle SA, GlaxoSmithKline Plc, Novartis AG, Merck & Co. Inc., Crescita Therapeutics Inc., Cipla Ltd., Taro Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Glenmark Pharmaceuticals Ltd., Bayer AG, Encore Dermatology, Inc., MedPharm Group Ltd., Skinvisible Pharmaceuticals, Inc., and Galderma S.A.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022E

Forecast Period: 2023F-2027F

Objective of the Study:

  • To analyze the historical growth in the market size of global topical drug delivery market from 2017 to 2021.
  • To estimate and forecast the market size of global topical drug delivery market from 2022E to 2027F and growth rate until 2027F.
  • To classify and forecast global topical drug delivery market based on product, route of administration, end user, distribution channel, regional distribution, and competitional landscape.
  • To identify dominant region or segment in the global topical drug delivery market.
  • To identify drivers and challenges for global topical drug delivery market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global topical drug delivery market.
  • To identify and analyze the profile of leading players operating in global topical drug delivery market.
  • To identify key sustainable strategies adopted by market players in global topical drug delivery market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies, suppliers, and service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies, which could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the globe.

TechSci Research calculated the market size of global topical drug delivery market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • End users, service providers and other stakeholders
  • Distributers and suppliers of topical drugs and other stakeholders
  • Organizations, forums, and alliances related to topical drug delivery market
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as vendors, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global Topical Drug Delivery market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Topical Drug Delivery Market, By Product:

Semi-Solid Formulations

Liquid Formulations

Solid Formulations

Transdermal Products

  • Global Topical Drug Delivery Market, By Route of Administration:

Dermal Drug Delivery

Ophthalmic Drug Delivery

Rectal Drug Delivery

Vaginal Drug Delivery

Nasal Drug Delivery

  • Global Topical Drug Delivery Market, By Distribution Channel:

Online

Offline

  • Global Topical Drug Delivery Market, By End User:

Hospitals

Clinics

Home Healthcare

Diagnostic Centers

Others

  • Global Topical Drug Delivery Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global topical drug delivery market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Topical Drug Delivery Market

5. Voice of Customer

6. Global Topical Drug Delivery Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products)
    • 6.2.2. By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery)
    • 6.2.3. By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others)
    • 6.2.4. By Distribution Channel (Online vs. Offline)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
  • 6.3. Product Market Map

7. North America Topical Drug Delivery Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Route of Administration
    • 7.2.3. By End User
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country (United States; Canada; Mexico)
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Topical Drug Delivery Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By End User
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Canada Topical Drug Delivery Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By End User
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. Mexico Topical Drug Delivery Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By End User
        • 7.3.3.2.4. By Distribution Channel

8. Europe Topical Drug Delivery Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Route of Administration
    • 8.2.3. By End User
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country (France; Germany; UK; Italy; Spain)
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Topical Drug Delivery Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By End User
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. Germany Topical Drug Delivery Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By End User
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. United Kingdom Topical Drug Delivery Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By End User
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. Italy Topical Drug Delivery Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Route of Administration
        • 8.3.4.2.3. By End User
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Spain Topical Drug Delivery Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Route of Administration
        • 8.3.5.2.3. By End User
        • 8.3.5.2.4. By Distribution Channel

9. Asia-Pacific Topical Drug Delivery Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Route of Administration
    • 9.2.3. By End User
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country (China; India; Japan; South Korea; Australia)
  • 9.3. Asia Pacific: Country Analysis
    • 9.3.1. China Topical Drug Delivery Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By End User
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. India Topical Drug Delivery Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By End User
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Japan Topical Drug Delivery Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By End User
        • 9.3.3.2.4. By Distribution Channel
    • 9.3.4. South Korea Topical Drug Delivery Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Route of Administration
        • 9.3.4.2.3. By End User
        • 9.3.4.2.4. By Distribution Channel
    • 9.3.5. Australia Topical Drug Delivery Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Route of Administration
        • 9.3.5.2.3. By End User
        • 9.3.5.2.4. By Distribution Channel

10. Middle East and Africa Topical Drug Delivery Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Route of Administration
    • 10.2.3. By End User
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country (UAE; Saudi Arabia; South Africa)
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Topical Drug Delivery Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By End User
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Topical Drug Delivery Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By End User
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Topical Drug Delivery Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By End User
        • 10.3.3.2.4. By Distribution Channel

11. South America Topical Drug Delivery Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Route of Administration
    • 11.2.3. By End User
    • 11.2.4. By Distribution Channel
    • 11.2.5. By Country (Brazil; Argentina; Colombia)
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Topical Drug Delivery Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Route of Administration
        • 11.3.1.2.3. By End User
        • 11.3.1.2.4. By Distribution Channel
    • 11.3.2. Argentina Topical Drug Delivery Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Route of Administration
        • 11.3.2.2.3. By End User
        • 11.3.2.2.4. By Distribution Channel
    • 11.3.3. Colombia Topical Drug Delivery Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Route of Administration
        • 11.3.3.2.3. By End User
        • 11.3.3.2.4. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Global Players Profiled (Leading Companies)
    • 14.2.1. Johnson & Johnson SA
    • 14.2.2. Nestle SA
    • 14.2.3. GlaxoSmithKline Plc
    • 14.2.4. Novartis AG
    • 14.2.5. Merck & Co. Inc.
    • 14.2.6. Crescita Therapeutics Inc.
    • 14.2.7. Cipla Ltd.
    • 14.2.8. Taro Pharmaceutical Industries Ltd.
    • 14.2.9. Valeant Pharmaceuticals International Inc.
    • 14.2.10. Glenmark Pharmaceuticals Ltd.
    • 14.2.11. Bayer AG
    • 14.2.12. Encore Dermatology, Inc.
    • 14.2.13. MedPharm Group Ltd.
    • 14.2.14. Skinvisible Pharmaceuticals, Inc.
    • 14.2.15. Galderma S.A.

15. Strategic Recommendations